Pittsburgh Cure Sarcoma
- Assets
- $195.6k
- Revenue
- $294.1k
- Investments
- $0.0
- Employees
- 0
- Location
- Wexford, PA
- Founding
- 12/2019
- Data as of
- 12/2023
- EIN
- 84-3322815
Organization Overview
Pittsburgh Cure Sarcoma is located in Wexford, PA. The organization was established in 2019. According to its NTEE Classification (G30) the organization is classified as: Cancer, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Pittsburgh Cure Sarcoma is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Pittsburgh Cure Sarcoma generated $294.1k in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 17.7% each year . All expenses for the organization totaled $357.4k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2021, Pittsburgh Cure Sarcoma has awarded 13 individual grants totaling $653,781. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
FUND AWARENESS AND RESEARCH FOR SARCOMA
Describe the Organization's Program Activity:
Part 3 - Line 4a
ALL DONATIONS MADE TO PITTSBURGH CURE SARCOMA ARE USED TO FUND AWARENESS AND RESEARCH FOR SARCOMA. IN 2023, PCS FINISHED PAYING THE 2022 GRANT SUBMISSIONS. THE PCS BOARD GRANTED AN ADDITIONAL 300,000 IN 2023 TO SUPPORT: DR. KURT WEISS AT THE MUSCULOSKELETAL ONCOLOGY LABRATORY IN THE UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE FOR 50,000; DR. KELLY BAILEY AT THE CHILDREN'S HOSPITAL OF PITTSBURGH FOR 35,000; DR. GIUSEPPE INTINI AT THE UNIVERSITY OF PITTSBURGH SCHOOL OF DENTAL MEDICINE FOR 34,992; DR. KURT WEISS AT THE UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE FOR 35,000; DR. INES LOHSE AT THE UPMC MUSCULOSKELETAL ONCOLOGY LABORATORY FOR 35,000; DR. LISA ERCOLANO AT WEST VIRGINIA UNIVERSITY FOR 34,200; DR. MOLLY KLEDZIK AT WEST VIRGINIA UNIVERSITY FOR 24,110; WEST VIRGINIA UNIVERSITY FOR 15,000; HILMAN CANCER CENTER SARCOMA FUND FOR 8,681; UPMC MUSCULOSKELETAL ONCOLOGY LABORATORY FOR 4,330; UPMC HILLMAN CANCER CENTER FOR 10,000; AND ALLEGHENY HEALTH NETWORK SARCOMA FUND FOR 13,681. FUND DISBURSEMENT CONTINUED INTO 2024.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
PDF Copies of 990 Filings
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Susan Cullinan Director | Trustee | 1.5 | $0 |
Sue Suit Emeritus Emeritus | Trustee | $0 | |
Mark Goodman President | OfficerTrustee | 4 | $0 |
Peter Kern Treasurer | OfficerTrustee | 2 | $0 |
Howard Louik Director | Trustee | 0.5 | $0 |
John Plassmeyer Vice Preside | OfficerTrustee | 1.5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $86,068 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $37,213 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $123,281 |
| Total Program Service Revenue | $0 |
| Investment income | $52 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $170,733 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $294,066 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $316,381 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $6,900 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $10,774 |
| Office expenses | $176 |
| Information technology | $14,031 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $879 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,373 |
| All other expenses | $0 |
| Total functional expenses | $357,416 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $37,572 |
| Savings and temporary cash investments | $158,059 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $195,631 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $195,631 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $195,631 |
Grants Awarded
Over the last fiscal year, Pittsburgh Cure Sarcoma has awarded $316,381 in support to 6 organizations.
| Grant Recipient | Amount |
|---|---|
UNIVERSITY OF PITTSBURGH PURPOSE: RESEARCH | $111,000 |
UPMC HILLMAN CANCER CENTER SARCOMA PURPOSE: RESEARCH | $10,000 |
CHILDREN'S HOSPITAL OF PITTSBURGH PURPOSE: RESEARCH | $35,000 |
WVU RESEARCH CORPORATION PURPOSE: RESEARCH | $50,000 |
ALLEGHENY HEALTH NETWORK PURPOSE: RESEARCH | $60,381 |
MOTOR PURPOSE: RESEARCH | $50,000 |